CoChat

Polycomb segment myeloid malignancies

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

An unexpected revelation of cancer genome studies has been frequent abnormality in genes for factors that modify chromatin, underscored in this issue of Blood by reports from Score et al and Kroeze et al of inactivating mutations and chromosome loss in SUZ12, EED and JARID2 in myelodysplastic syndrome (MDS) and myeloproliferative disease (MPD).

Overview

Integrity signals

Registry

Crossref · 10.1182/blood-2011-12-391268

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 14 references

Cited by

See all 13

Metadata

Authors
Saunthararajah, Y., & Maciejewski, J.
Affiliations
Cleveland Clinic (US)
Venue
Blood
Published
2012-02-02
Volume
119
Issue
5
Pages
1097-1098
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2019223103
Cited by
12
References
14
Citations by year
2020: 1 · 2019: 1 · 2016: 1 · 2015: 3 · 2014: 1 · 2013: 3 · 2012: 2
FWCI
1.92
Type
journal article
Language
en
Open access
closed
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Cancer Institute (R01CA138858)
Topics
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords
Polycomb group genes, myeloid neoplasms, SUZ12, EED, JARID2, chromatin modification, loss-of-function mutations, chromosome loss, myelodysplastic syndrome, myeloproliferative neoplasms, cancer genome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Polycomb segment myeloid malignancies. https://app.cochat.ai/papers/10.1182/blood-2011-12-391268
The paper
Saunthararajah, Y., & Maciejewski, J. (2012). Polycomb segment myeloid malignancies. Blood. https://doi.org/10.1182/blood-2011-12-391268

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.